Massachusetts Financial Services’s CG Oncology CGON Stock Holding History

Massachusetts Financial Services’s Portfolio CGON Stock Details CGON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11M	Buy	155,390 +18,549	+14%	+$1.21M	﹤0.01%	755
2026 Q1	$9.26M	Sell	136,841 -65,077	-32%	-$3.69M	﹤0.01%	732
2025 Q4	$8.38M	Sell	201,918 -45,831	-18%	-$1.9M	﹤0.01%	723
2025 Q3	$9.98M	Sell	247,749 -1,915	-0.8%	-$55.7K	﹤0.01%	690
2025 Q2	$6.49M	Sell	249,664 -8,426	-3%	-$203K	﹤0.01%	700
2025 Q1	$6.32M	Buy	258,090 +933	+0.4%	+$26.2K	﹤0.01%	685
2024 Q4	$7.38M	Sell	257,157 -22,788	-8%	-$780K	﹤0.01%	667
2024 Q3	$10.6M	Buy	279,945 +13,158	+5%	+$461K	﹤0.01%	638
2024 Q2	$8.42M	Buy	266,787 +6,899	+3%	+$239K	﹤0.01%	655
2024 Q1	$11.4M	Buy	+259,888	New	+$10.6M	﹤0.01%	617

Other funds holding CGON

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services's CGON Position: Q2 2026 in Review

Massachusetts Financial Services increased its CG Oncology (CGON) stake by 14% in Q2 2026, buying an estimated $1.21M and bringing the position to 155,390 shares worth $11M. The position accounts for ﹤0.01% of the portfolio, ranked #755.

Massachusetts Financial Services first reported a position in CGON in Q1 2024 and has held it in 10 quarters since. The position peaked at $11.4M in Q1 2024. 228 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

Massachusetts Financial Services held 155,390 shares of CG Oncology worth $11M as of Q2 2026.
Massachusetts Financial Services bought 18,549 CG Oncology shares in Q2 2026, an estimated $1.21M.
CG Oncology made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #755 holding.
Massachusetts Financial Services first reported a position in CG Oncology in Q1 2024 and has held it in 10 quarters since.
Massachusetts Financial Services's CG Oncology position peaked at $11.4M in Q1 2024.
228 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.